Browse Category

Earnings Reports News 23 January 2026

SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB stock price swings after earnings beat, dividend hike and Venezuela signals

NEW YORK, Jan 23, 2026, 15:37 (EST) — Regular session SLB shares gained roughly 0.3% to $49.47 in Friday afternoon trading, after jumping as much as 4.7% earlier. The oilfield services company’s quarterly update sparked early buying but momentum faded as investors digested guidance and news around Venezuela. This shift is significant as oilfield service stocks juggle two narratives: will…
Qualcomm stock slips today as QCOM proxy vote and Feb. 4 earnings draw focus

Qualcomm stock slips today as QCOM proxy vote and Feb. 4 earnings draw focus

New York, January 23, 2026, 15:37 (EST) — Regular session Shares of Qualcomm Incorporated dipped roughly 1.7% to $155.15 in Friday afternoon trading, putting the company’s market cap near $168 billion. The Nasdaq-listed stock fluctuated between $155.06 and $158.10, with around 4.2 million shares traded. This shift arrives ahead of a packed schedule for the wireless-chip maker, which faces an…
Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

Life360 stock jumps 22% as record Q4 user growth lifts outlook ahead of March results

New York, January 23, 2026, 15:22 EST — Regular session Life360 shares surged roughly 22% on Friday following the family-safety app maker’s report of record fourth-quarter user growth and stronger-than-anticipated preliminary results. The stock climbed $12.09 to $66.90 in afternoon trading, hitting a high of $71.17 earlier in the day. This move is significant since Life360 has started trading like…
PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

New York, Jan 23, 2026, 15:24 EST — Regular session PepsiCo (PEP.O) shares edged down 0.2% to $144.05 on Friday, underperforming the broader consumer staples sector, which saw gains. The snack-and-soda giant is falling behind some of its bigger rivals. The market stumbled on uncertain footing. Intel’s forecast shook investor nerves, leaving U.S. stocks without a clear trend. According to…
Bloom Energy stock drops as Clear Street hikes target, but keeps Hold ahead of earnings

Bloom Energy stock drops as Clear Street hikes target, but keeps Hold ahead of earnings

New York, Jan 23, 2026, 15:00 (EST) — Regular session Shares of Bloom Energy Corp (BE) dropped 2.9%, closing at $141.41 Friday afternoon. The stock fluctuated between $138.02 and $148.10 earlier in the session. The pullback is significant because Bloom has become a quick barometer for one key issue: how fast major power consumers, particularly data centers, can secure steady…
B2Gold stock price today: BTG edges up as gold nears $5,000 and Feb. 18 earnings loom

B2Gold stock price today: BTG edges up as gold nears $5,000 and Feb. 18 earnings loom

Vancouver, Jan 23, 2026, 11:58 PT — Regular session. B2Gold Corp shares inched up Friday, buoyed by a renewed jump in gold prices and a calendar that’s gaining importance for miners. By 2:42 p.m. ET, the U.S.-listed stock had risen roughly 0.7% to $5.24, after swinging between $5.16 and $5.38. The move arrives as gold miners act like a live…
Amphenol stock slips as Wall Street waits for earnings next week

Amphenol stock slips as Wall Street waits for earnings next week

New York, Jan 23, 2026, 15:15 EST — Regular session Shares of Amphenol Corp dipped roughly 0.9% to $151.14 on Friday, with investors pulling back ahead of the company’s earnings report due next week. The pullback is significant since Amphenol has hovered close to recent peaks. The upcoming update offers one of the earliest clear signals on demand across its…
AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings

AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings

New York, Jan 23, 2026, 15:06 EST — Regular session AbbVie Inc. shares rose about 0.6% on Friday after an Indian report said the country’s patent office rejected the drugmaker’s bid to patent venetoclax, a blood-cancer treatment sold as Venclexta. The stock was up 0.6% at $219.33 in afternoon trade, even as the Health Care Select Sector SPDR Fund fell…
Super Micro (SMCI) stock flips lower after early pop as Feb. 3 earnings loom

Super Micro (SMCI) stock flips lower after early pop as Feb. 3 earnings loom

New York, Jan 23, 2026, 14:57 EST — Regular session Super Micro Computer shares dropped 2.5% to $31.64 on Friday, erasing gains from an early rally as investors braced for the upcoming earnings report. The stock started the day stronger, hitting $33.71 before sliding down to $31.33. The date is crucial since Super Micro’s results have turned into a key…
Apple stock slips as China discounts and memory-chip costs sharpen focus on next week’s earnings

Apple stock slips as China discounts and memory-chip costs sharpen focus on next week’s earnings

NEW YORK, Jan 23, 2026, 14:54 ET — Regular session Apple Inc (AAPL.O) shares edged down roughly 0.3% to $247.71 in Friday’s afternoon session, as investors weighed new reports of discounting in China alongside growing concerns over rising component costs ahead of next week’s earnings. During the session, the stock fluctuated between $244.73 and $249.40. The move was minor, yet…
SLB stock price swings after earnings beat as $4 billion return plan meets Venezuela questions

SLB stock price swings after earnings beat as $4 billion return plan meets Venezuela questions

New York, January 23, 2026, 14:49 EST — Regular session underway. SLB (NYSE: SLB) shares held steady near $49.33 Friday afternoon, after earlier fluctuating between $48.65 and $51.66. Trading volume was notably high as investors digested an earnings beat offset by a cautious short-term outlook. This update is key since SLB is at the heart of worldwide oilfield spending. Traders…
Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

New York, January 23, 2026, 14:26 EST — Regular session Pfizer (PFE.N) shares dropped roughly 1.9% to $25.62 Friday afternoon, underperforming the health-care sector as the stock went ex-dividend. The Health Care Select Sector SPDR Fund (XLV) dipped about 0.5%, while the SPDR S&P 500 ETF Trust (SPY) inched up around 0.1%. Merck (MRK.N) slipped about 1%, and Moderna (MRNA.O)…
1 92 93 94 95 96 329

Stock Market Today

  • Rolls-Royce Holdings Shares Surge 102% in One Year But May Be Overvalued
    February 5, 2026, 10:00 PM EST. Rolls-Royce Holdings' stock has surged 102% over the last year, reflecting strong investor confidence amid its ongoing turnaround. However, recent analysis using a Discounted Cash Flow (DCF) model suggests the shares might be overvalued by about 20%, with an implied intrinsic value of £10.06 per share against current market prices. Over the past 30 days, the stock dipped 3%, prompting reconsideration of risk versus reward. Despite strong returns over three to five years, valuation scores remain moderate, with a 3 out of 6 rating. Investors are weighing whether market optimism has outpaced fundamental performance in the aerospace and defense sector.
Go toTop